Article

A microneedle-based delivery system for broad-protection seasonal influenza A DNA nanovaccines

2023-05-26

Abstract excerpt

Seasonal influenza A viruses continue to pose a public health threat, and current vaccines are not sufficiently effective because of virus mutation. There is an urgent need to develop a broad-protection influenza A vaccine. Our team previously designed potential universal hemagglutinin (HA) sequences against seasonal influenza A H1N1 and H3N2 (mH1 and mH3, respectively) through a mosaic strategy. In this study, we...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3c85f43c-f98b-54d6-b33a-c1d689c11073
DOI: 10.1016/j.xcrp.2023.101430

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A microneedle-based delivery system for broad-protection seasonal influenza A DNA nanovaccinesDOI 10.1016/j.xcrp.2023.101430Read

Development of an mRNA vaccine against a panel of heterologous H1N1 seasonal influenza viruses using a consensus hemagglutinin sequenceSemantic proximity Read

Advances in Nanoparticle-Enhanced Vaccine Strategies: Towards a Universal Protection Against Influenza B VirusesSemantic proximity Read

Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protectionSemantic proximity Read

Evaluation of SWCNTs-loaded DNA vaccine encoding predominant antigen epitope VP4-3 against type II GCRVSemantic proximity Read

M2e nanovaccines supplemented with recombinant hemagglutinin protect chickens against heterologous HPAI H5N1 challengeSemantic proximity Read

Digitally immune optimised haemagglutinin with nanocage plug-and-display elicits broadly neutralising pan-H5 influenza subtype vaccine responsesSemantic proximity Read

Advances in Nucleic Acid Universal Influenza VaccinesSemantic proximity Read

Single-component multilayered self-assembling protein nanoparticles displaying extracellular domains of matrix protein 2 as a pan-influenza A vaccineSemantic proximity Read

Eliciting B cell immunity against infectious diseases using nanovaccines.Semantic proximity Read

In Vivo Assembly of Nanoparticles Achieved through Synergy of Structure‐Based Protein Engineering and Synthetic DNA Generates Enhanced Adaptive ImmunitySemantic proximity Read

Nanostructured lipid carriers overcome the low immunogenicity of M2e peptide via surface click chemistry conjugation, improving the anti-M2e antibody responseSemantic proximity Read

Single-Component Multilayered Self-Assembling Protein Nanoparticles Displaying Extracellular Domains of Matrix Protein 2 as a Pan-influenza A VaccineSemantic proximity Read